Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap60.66M
Market cap60.66M
Price-Earnings ratio-1.11
Price-Earnings ratio-1.11
Dividend yield—
Dividend yield—
Average volume315.69K
Average volume315.69K
High today$0.43
High today$0.43
Low today$0.402
Low today$0.402
Open price$0.422
Open price$0.422
Volume390.01K
Volume390.01K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.2928
52 Week low$0.2928
IMMP News
TipRanks 6d
Immutep granted new patent for eftilagimod alfa combinationImmutep (IMMP) announced the grant of a new patent entitled “Combined Preparations for the Treatment of Cancer or Infection” by the United States Patent and Tra...
Investing.com 6d
Citizens maintains Immutep stock rating on cash analysis - Investing.com...
TipRanks 6d
Immutep Wins Fourth U.S. Patent for Key Cancer Immunotherapy CombinationTipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.